Bennicas & Associates’s Gabelli Healthcare & Wellness Trust GRX Stock Holding History

Bennicas & Associates’s Portfolio GRX Stock Details GRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$1.7M	Sell	165,200 -1,200	-0.7%	-$12.1K	0.98%	35
2022 Q3	$1.58M	Sell	166,400 -1,000	-0.6%	-$11.1K	1.01%	35
2022 Q2	$1.79M	Hold	167,400	–	–	1.05%	34
2022 Q1	$2.15M	Hold	167,400	–	–	1.08%	32
2021 Q4	$2.27M	Hold	167,400	–	–	1.18%	28
2021 Q3	$2.21M	Sell	167,400 -1,000	-0.6%	-$13.5K	1.24%	25
2021 Q2	$2.27M	Hold	168,400	–	–	1.25%	24
2021 Q1	$2.1M	Sell	168,400 -2,000	-1%	-$24.5K	1.2%	25
2020 Q4	$2.04M	Sell	170,400 -500	-0.3%	-$5.54K	1.19%	22
2020 Q3	$1.76M	Sell	170,900 -1,300	-0.8%	-$13.6K	1.1%	27
2020 Q2	$1.73M	Hold	172,200	–	–	1.3%	24
2020 Q1	$1.49M	Sell	172,200 -1,000	-0.6%	-$10.6K	1.32%	25
2019 Q4	$2M	Buy	173,200 +35,700	+26%	+$385K	1.44%	23
2019 Q3	$1.43M	Hold	137,500	–	–	1.11%	35
2019 Q2	$1.45M	Buy	+137,500	New	+$1.44M	1.21%	31

Other funds holding GRX

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

GAMCO Investors Greenwich, Connecticut $10.2B AUM 30.27% 1-Year Est. Return

TJHA

Thomas J. Herzfeld Advisors Miami Beach, Florida $294M AUM 2.62% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Cetera Investment Advisers Schaumburg, Illinois $94B AUM 20.14% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

ACP

Aviance Capital Partners Naples, Florida $854M AUM 25.16% 1-Year Est. Return

WAP

Wealthcare Advisory Partners West Chester, Pennsylvania $5.27B AUM 22.23% 1-Year Est. Return

Bennicas & Associates's GRX Position: Q4 2022 in Review

Bennicas & Associates reduced its Gabelli Healthcare & Wellness Trust (GRX) stake by 0.72% in Q4 2022, selling an estimated $12.1K and leaving 165,200 shares worth $1.7M. The position accounts for 0.98% of the portfolio, ranked #35.

Bennicas & Associates first reported a position in GRX in Q2 2019 and has held it in 15 quarters since. The position peaked at $2.27M in Q2 2021. 67 funds tracked by Wall St. Rank hold GRX as of Q4 2022.

Bennicas & Associates held 165,200 shares of Gabelli Healthcare & Wellness Trust worth $1.7M as of Q4 2022.
Bennicas & Associates sold 1,200 Gabelli Healthcare & Wellness Trust shares in Q4 2022, an estimated $12.1K.
Gabelli Healthcare & Wellness Trust made up 0.98% of Bennicas & Associates's portfolio in Q4 2022, its #35 holding.
Bennicas & Associates first reported a position in Gabelli Healthcare & Wellness Trust in Q2 2019 and has held it in 15 quarters since.
Bennicas & Associates's Gabelli Healthcare & Wellness Trust position peaked at $2.27M in Q2 2021.
67 funds tracked by Wall St. Rank held Gabelli Healthcare & Wellness Trust as of Q4 2022.

Based on Bennicas & Associates's 13F filing for Q4 2022, filed 12 Jan 2023.